Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.
Solid Biosciences (SLDB) stock retains a "Strong Buy" rating, driven by robust interim data for SGT-003 in pediatric Duchenne ...
This study presents valuable findings that could potentially allow a deeper understanding of the immunopathogenesis underlying influenza infection in aged mice. The results are based on solid evidence ...
Something happens when a rat starts running. Not just the obvious things, the faster heart, the warming muscles, the rhythmic percussion of paws against the wheel. Something quieter. Something that ...
Voluntary exercise reshapes gut microbiota and tryptophan metabolism, with consequences for the hippocampus, the ...
FORT MYERS, FL, UNITED STATES, March 5, 2026 /EINPresswire.com/ -- Autism rates have reached historic highs, leaving ...
9d
Copper Quest Completes AI-Driven Analysis at Kitimat & Identifies Large Concealed Conductive Target
Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce the completion of its AI-driven geological analysis at its 100%-owned Kitimat ...
Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...
Artificial intelligence company Rilla has signed a 10-year lease for 57,350 square feet at 25 Kent Avenue in Williamsburg, Brooklyn. The asking rent was $76 per square foot, according to The Real Deal ...
A firm’s reputation can suffer even when it has done nothing wrong. When a peer experiences a crisis—whether a product safety failure, a regulatory violation, or a high-profile scandal—customers, ...
Wedbush analyst Scott Devitt shrugs off concerns about rising capital expenditures, noting that artificial intelligence is already boosting Meta's advertising engine Meta joins Apple, Tesla and ...
Mast interviewed more than two dozen former and current Moderna employees, along with analysts, rival executives, investors, and experts in mRNA and vaccines to understand how the company arrived at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results